Promiscuous expression of Epstein-Barr virus genes in Burkitt's lymphoma from the central African country Malawi

International Journal of Cancer

Volumn 99, Issue 5, 2002, Pages 635-643

  Xue, Shao An ^a,b   Labrecque, Louise G ^c   Lu, Qi Long ^d   Ong, S Kate ^a   Lampert, Irvin A ^d   Kazembe, Peter ^e   Molyneux, Elizabeth ^f   Broadhead, Robin L ^f   Borgstein, Eric ^f   Griffin, Beverly E ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b SHAANXI NORMAL UNIVERSITY   (China)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e Lilongwe Central Hospital   (Malawi)

^f UNIVERSITY OF MALAWI   (Malawi)

Author keywords

Early gene; Epstein Barr virus; Fine needle aspirate; IL 10; Immediate early gene; RT PCR

Indexed keywords

CYTOKINE; GENE PRODUCT; INTERLEUKIN 10; MEMBRANE PROTEIN; METHANOL; PROTEIN BCL 2; PROTEIN IR2; PROTEIN IR4; UNCLASSIFIED DRUG; VIRUS RNA;

ARTICLE; ASPIRATION BIOPSY; BURKITT LYMPHOMA; CELL DEATH; CELL POPULATION; CENTRAL AFRICA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MALAWI; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE; VIRUS LATENCY; VIRUS ONCOGENE;

EID: 20244388788     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10372     Document Type: Article

References (48)

1. Carcinogens in the nose and throat: Nasopharyngeal carcinoma in Kenya
2. Burkitt on Burkitt's lymphoma
3. Correlation between cytopathological results and in situ hybridisation on needle aspiration biopsies of suspected African Burkitt's lymphomas
4. Expression of Epstein-Barr virus lytically related genes in African Burkitt's lymphoma: Correlation with patient response to therapy
5. African Burkitt's lymphoma: A new perspective
6. Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue
7. Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma
8. Expression of Epstein-Barr virus gene products in Burkitt's lymphoma in northeast Brazil
9. Expression of two related viral early genes in Epstein-Barr virusassociated tumors
10. A new blocking method for application of murine monoclonal antibody to mouse tissue sections
11. Identification of the gene product encoded by the PstI repeats (IR4) of the Epstein-Barr virus genome
12. Sequential use of paraformaldehyde and methanol as optimal conditions for the direct quantification of ZEBRA and rta antigens by flow cytometry
13. Activity of EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders
14. Differential splicing of Epstein-Barr virus immediate-early RNA
15. EBV gene expression in an NPC-related tumour
16. Strain variation in Epstein-Barr virus immediate early genes
17. Amino-acid change in the Epstein-Barr-virus ZEBRA protein in undifferentiated nasopharyngeal carcinomas from Europe and North Africa
18. Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats
19. Homology of cytokine synthesis inhibitory factory (IL-10) to the Epstein-Barr virus gene BCRF1
20. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells
21. Epstein-Barr virus
22. Cell proliferation in Burkitt's tumours
23. Cell kinetics of African cases of Burkitt's lymphoma
24. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies
25. Sensitivity of an Epstein-Barr viruspositive tumor line, Daudi, to alpha interferon correlates with expression of a GC-rich viral transcript
26. Viruses and interferons
27. A transforming function of the BARF1 gene encoded by Epstein-Barr virus
28. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte cell line
29. Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells
30. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors
31. Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus
32. Expression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice
33. Epstein-Barr virus. Biology, pathogenesis and medical aspects
34. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda
35. Interteukin-10 and the interleukin-10 receptor
36. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines
37. The latency pattern of Epstein-Barr infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas
38. Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma
39. Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma
40. Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease
41. DNA sequence and expression of the B95-8 Epstein-Barr virus genome
42. Epstein-Barr virus-encoded poly (A)-RNA supports Burkitt's lymphoma growth through interleukin-10 induction
43. Epstein-Barr virus infections and their association with human malignancies: Some key questions
44. Dominant cytotoxic T lymphocyte response to the immediate-early trans-activator protein, BZLF1, in persistent type A or B Epstein-Barr virus infection
45. Responsiveness of the Epstein-Barr virus NotI repeat promoter to the Z transactivator is mediated in a cell-type-specific manner by two independent signal regions